CD44 is required for two consecutive steps in HGF/c-Met signaling

Genes and Development

Volumn 16, Issue 23, 2002, Pages 3074-3086

  Orian Rousseau, Véronique ^a   Chen, Linfeng ^a   Sleeman, Jonathan P ^a   Herrlich, Peter ^a   Ponta, Helmut ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

CD44 splice variants; Ezrin; Gab 1; Invasiveness; Scattering

Indexed keywords

ANTIBODY; EPITOPE; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; SCATTER FACTOR;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOPLASM; EXON; GENE SEQUENCE; GENETIC CODE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN VARIANT; RAT; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANTIGENS, CD44; CELL LINE; COLONIC NEOPLASMS; HEPARITIN SULFATE; HEPATOCYTE GROWTH FACTOR; HUMANS; KERATINOCYTES; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0036896923     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.242602     Document Type: Article

References (65)

1. Bardelli, A. and Comoglio, P.M. 1997. Scatter factor receptors are key players in a unique multistep program leading to invasive growth. Ciba Found. Symp. 212: 133-144.
2. Bardelli, A., Pugliese, L., and Comoglio, P.M. 1997. "Invasive-growth" signaling by the Met/HGF receptor: The hereditary renal carcinoma connection. Biochim. Biophys. Acta 1333: 41-51.
3. Behrens, J., Mareel, M.M., Van Roy, F.M., and Birchmeier, W. 1989. Dissecting tumor cell invasion: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J. Cell. Biol. 108: 2435-2447.
4. Bennett, K.L., Jackson, D.G., Simon, J.C., Tanczos, E., Peach, R., Modrell, B., Stamenkovic, I., Plowman, G., and Aruffo, A. 1995. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell. Biol. 128: 687-698.
5. Birchmeier, C. and Gherardi, E. 1998. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8: 404-410.
6. Bourguignon, L.Y., Zhu, H., Chu, A., Iida, N., Zhang, L., and Hung, M.C. 1997. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J. Biol. Chem. 272: 27913-27918.
7. Bourguignon, L.Y., Zhu, H., Shao, L., and Chen, Y.W. 2001. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J. Biol. Chem. 276: 7327-7336.
8. Camenisch, T.D., Spicer, A.P., Brehm-Gibson, T., Biesterfeldt, J., Augustine, M.L., Calabro Jr., A., Kubalak, S., Klewer, S.E., and McDonald, J.A. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest. 106: 349-360.
9. Cavallaro, U., Niedermeyer, J., Fuxa, M., and Christofori, G. 2001. N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat. Cell Biol. 3: 650-657.
10. Crepaldi, T., Gautreau, A., Comoglio, P.M., Louvard, D., and Arpin, M. 1997. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell. Biol. 138: 423-434.
11. Fazioli, F., Wong, W.T., Ullrich, S.J., Sakaguchi, K., Appella, E., and Di Fiore, P.P. 1993. The ezrin-like family of tyrosine kinase substrates: Receptor-specific pattern of tyrosine phosphorylation and relationship to malignant transformation. Oncogene 8: 1335-1345.
12. Fisher, P.B., Babiss, L.E., Weinstein, I.B., and Ginsberg, H.S. 1982. Analysis of type 5 adenovirus transformation with a cloned rat embryo cell line (CREF). Proc. Natl. Acad. Sci. 79: 3527-3531.
13. Fujisaki, T., Tanaka, Y., Fujii, K., Mine, S., Saito, K., Yamada, S., Yamashita, U., Irimura, T., and Eto, S. 1999. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res. 59: 4427-4434.
14. Giordano, S., Zhen, Z., Medico, E., Gaudino, G., Galimi, F., and Comoglio, P.M. 1993. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. Proc. Natl. Acad. Sci. 90: 649-653.
15. Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Haußmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24.
16. Habets, G.G., Scholtes, E.H., Zuydgeest, D., van der Kammen, R.A., Stam, J.C., Berns, A., and Collard, J.G. 1994. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77: 537-549.
17. Hartmann, G., Prospero, T., Brinkmann, V., Ozcelik, C., Winter, G., Hepple, J., Batley, S., Bladt, F., Sachs, M., Birchmeier, C., et al. 1998. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr. Biol. 8: 125-134. (Erratum published in: 1998. Curr. Biol. 8: R739.)
18. Hobson, J.P., Rosenfeldt, H.M., Barak, L.S., Olivera, A., Poulton, S., Caron, M.G., Milstien, S., and Spiegel, S. 2001. Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility. Science 291: 1800-1803.
19. Hofmann, M., Rudy, W., Gunthert, U., Zimmer, S.G., Zawadzki, V., Zoller, M., Lichtner, R.B., Herrlich, P., and Ponta, H. 1993. A link between ras and metastatic behavior of tumor cells: Ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res. 53: 1516-1521.
20. Hudson, D.L., Sleeman, J., and Watt, F.M. 1995. CD44 is the major peanut lectin-binding glycoprotein of human epidermal keratinocytes and plays a role in intercellular adhesion. J. Cell. Sci. 108: 1959-1970.
21. Katagiri, Y.U., Sleeman, J., Fujii, H., Herrlich, P., Hotta, H., Tanaka, K., Chikuma, S., Yagita, H., Okumura, K., Murakami, M., et al. 1999. CD44 variants but not CD44s cooperate with β1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res. 59: 219-226.
22. Kaya, G., Rodriguez, I., Jorcano, J.L., Vassalli, P., and Stamenkovic, I. 1997. Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene driven by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes & Dev. 11: 996-1007.
23. Khaldoyanidi, S., Karakhanova, S., Sleeman, J., Herrlich, P., and Ponta, H. 2002. CD44 variant-specific antibodies trigger hemopoiesis by selective release of cytokines from bone marrow macrophages. Blood 99: 3955-3961.
24. König, H., Moll, J., Ponta, H., and Herrlich, P. 1996. Transacting factors regulate the expression of CD44 splice variants. EMBO J. 15: 4030-4039.
25. König, H., Ponta, H., and Herrlich, P. 1998. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J. 10: 2904-2913.
26. Kulas, D.T., Goldstein, B.J., and Mooney, R.A. 1996. The transmembrane protein-tyrosine phosphatase LAR modulates signaling by multiple receptor tyrosine kinases. J. Biol. Chem. 271: 748-754.
27. Legg, J.W. and Isacke, C.M. 1998. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr. Biol. 8: 705-708.
28. Matzku, S., Komitowski, D., Mildenberger, M., and Zoller, M. 1983. Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. Invasion Metastasis 3: 109-123.
29. Matzku, S., Wenzel, A., Liu, S., and Zoller, M. 1989. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res. 49: 1294-1299.
30. Medico, E., Gentile, A., Lo Celso, C., Williams, T.A., Gambarotta, G., Trusolino, L., and Comoglio, P.M. 2001. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth. Cancer Res. 61: 5861-5868.
31. Mizuno, K., Inoue, H., Hagiya, M., Shimizu, S., Nose, T., Shimohigashi, Y., and Nakamura, T. 1994. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J. Biol. Chem. 269: 1131-1136.
32. Morrison, H., Sherman, L.S., Legg, J., Banine, F., Isacke, C., Haipek, C.A., Gutmann, D.H., Ponta, H., and Herrlich, P. 2001. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes & Dev. 15: 968-980.
33. Naka, D., Ishii, T., Yoshiyama, Y., Miyazawa, K., Hara, H., Hishida, T., and Kidamura, N. 1992. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. J. Biol. Chem. 267: 20114-20119.
34. Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F., and Comoglio, P.M. 1992. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 11: 4825-4833.
35. Naor, D., Sionov, R.V., and Ish-Shalom, D. 1997. CD44: Structure, function and association with the malignant process. In Advances in Cancer Research (eds. G.F. Vande Woude and G. Klein), pp. 243-318. Academic Press, San Diego, CA.
36. Nestl, A., Von Stein, O.D., Zatloukal, K., Thies, W.G., Herrlich, P., Hofmann, M., and Sleeman, J.P. 2001. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res. 61: 1569-1577.
37. Plotnikov, A.N., Schlessinger, J., Hubbard, S.R., and Mohammadi, M. 1999. Structural basis for FGF receptor dimerization and activation. Cell 98: 641-650.
38. Ponta, H. and Herrlich, P. 1998. The CD44 protein family: Roles in embryogenesis and tumor progression. Front. Biosci. 3: d650-d656.
39. Ponta, H., Wainwright, D., and Herrlich, P. 1998. The CD44 protein family. Int. J. Biochem. Cell. Biol. 30: 299-305.
40. Protin, U., Schweighoffer, T., Jochum, W., and Hilberg, F. 1999. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. J. Immunol. 163:4917-4923.
41. Reeder, J.A., Gotley, D.C., Walsh, M.D., Fawcett, J., and Antalis, T.M. 1998. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment. Cancer Res. 58: 3719-3726.
42. Rodrigues, G.A. and Park, M. 1993. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol. Cell. Biol. 13: 6711-6722.
43. Rong, S., Segal, S., Anver, M., Resau, J.H., and Vande Woude, G.F. 1994. Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc. Natl. Acad. Sci. 91: 4731-4735.
44. Rudy, W., Hofmann, M., Schwartz-Albiez, R., Zoller, M., Heider, K.H., Ponta, H., and Herrlich, P. 1993. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: Each one individually suffices to confer metastatic behavior. Cancer Res. 53: 1262-1268.
45. Schlessinger, J., Lax, I., and Lemmon, M. 1995. Regulation of growth factor activation by proteoglycans: What is the role of the low affinity receptors? Cell 83: 357-360.
46. Schmits, R., Filmus, J., Gerwin, N., Senaldi, G., Kiefer, F., Kundig, T., Wakeham, A., Shahinian, A., Catzavelos, C., Rak, J., et al. 1997. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90: 2217-2233.
47. Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., and Zoller, M. 1993. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp. Med. 177: 443-455.
48. Sherman, L., Wainwright, D., Ponta, H., and Herrlich, P. 1998. A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes & Dev. 12: 1058-1071.
49. Sherman, L.S., Rizvi, T.A., Karyala, S., and Ratner, N. 2000. CD44 enhances neuregulin signaling by Schwann cells. J. Cell. Biol. 150: 1071-1084.
50. Sleeman, J.P., Arming, S., Moll, J.F., Hekele, A., Rudy, W., Sherman, L.S., Kreil, G., Ponta, H., and Herrlich, P. 1996a. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res. 56: 3134-3141.
51. Sleeman, J., Rudy, W., Hofmann, M., Moll, J., Herrlich, P., and Ponta, H. 1996b. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J. Cell. Biol 135: 1139-1150
52. Sleeman, J., Kondo, K., Moll, J., Ponta, H., and Herrlich, P. 1997. Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J. Biol. Chem. 272: 31837-31844.
53. Tanaka, Y., Adams, D.H., Hubscher, S., Hirano, H., Siebenlist, U., and Shaw, S. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1b. Nature 361: 79-82.
54. Trowbridge, I.S., Lesley, J., Schulte, R., Hyman, R., and Trotter, J. 1982. Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 15: 299-312.
55. Trusolino, L., Bertotti, A., and Comoglio, P.M. 2001. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth. Cell 107: 643-654.
56. Tsukita, S. and Yonemura, S. 1999. Cortical actin organization: Lessons from ERM (ezrin/radixin/moesin) proteins. J. Biol. Chem. 274: 34507-34510.
57. van der Voort, R., Manten-Horst, E., Smit, L., Ostermann, E., van den Berg, F., and Pals, S.T. 1995. Binding of cell-surface expressed CD44 to hyaluronate is dependent on splicing and cell type. Biochem. Biophys. Res. Comm. 214: 137-144.
58. van der Voort, R., Taher, T.E., Wielenga, V.J., Spaargaren, M., Prevo, R., Smit, L., David, G., Hartmann, G., Gherardi, E., and Pals, S.T. 1999. Heparansulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J. Biol. Chem. 274: 6499-6506.
59. van Weering, D.H., Baas, P.D., and Bos, J.L. 1993. A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl. 3: 100-106.
60. Vasioukhin, V., Bauer, C., Degenstein, L., Wise, B., and Fuchs, E. 2001. Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin. Cell 104: 605-617.
61. Vigna, E., Gramaglia, D., Longati, P., Bardelli, A., and Comoglio, P.M. 1999. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPRMET. Oncogene 18: 4275-4281.
62. Villa-Moruzzi, E., Puntoni, F., Bardelli, A., Vigna, E., De Rosa, S., and Comoglio, P.M. 1998. Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met. Biochem. J. 336: 235-239.
63. Whitmarsh, A.J., Cavanagh, J., Tournier, C., Yasuda, J., and Davis, R.J. 1998. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science 281: 1671-1674.
64. Yasuda, J., Whitmarsh, A.J., Cavanagh, J., Sharma, M., and Davis, R.J. 1999. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell. Biol. 19: 7245-7254.
65. Yu, Q. and Stamenkovic, I. 1999. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes & Dev. 13: 35-48.